These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8364165)
1. Age-related changes in gonadotropin, prolactin and growth hormone levels with reference to the development of uterine adenomyosis in female SHN mice. Singtripop T; Mori T; Shiraishi K; Park MK; Kawashima S In Vivo; 1993; 7(2):147-50. PubMed ID: 8364165 [TBL] [Abstract][Full Text] [Related]
2. Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally. Nagasawa H; Noguchi Y; Mori T; Niki K; Namiki H Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1547-51. PubMed ID: 3830732 [TBL] [Abstract][Full Text] [Related]
3. Circulating levels of prolactin and growth hormone and natural incidence of mammary tumors in mice. Sinha YN; Salocks CB; VanderLaan WP J Toxicol Environ Health Suppl; 1976; 1():131-60. PubMed ID: 994231 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of mammary tumourigenesis and inhibition of uterine adenomyosis by suppressed progesterone effects in SHN mice. Nagasawa H; Aoki M; Mori T; Yamamoto K; Inaba T; Mori J Anticancer Res; 1989; 9(4):827-32. PubMed ID: 2817809 [TBL] [Abstract][Full Text] [Related]
5. Prolactin and growth hormone levels in different inbred strains of mice: patterns in association with estrous cycle, time of day, and perphenazine stimulation. Sinha YN; Salocks CB; Vanderlaan WP Endocrinology; 1975 Nov; 97(5):1112-22. PubMed ID: 1237395 [TBL] [Abstract][Full Text] [Related]
6. Effects of treatment with prolactin or progesterone on the coincidence of mammary tumors and uterine adenomyosis in young SHN mice. Nagasawa H; Ishida M; Mori T Lab Anim Sci; 1987 Apr; 37(2):200-2. PubMed ID: 2885443 [TBL] [Abstract][Full Text] [Related]
7. Difference in response to mammotropic hormones of mammary growth and uterine adenomyosis among four strains of mice. Nagasawa H; Naito T; Mori T In Vivo; 1988; 2(2):171-5. PubMed ID: 2979835 [TBL] [Abstract][Full Text] [Related]
8. Molecular size variants of prolactin and growth hormone in mouse serum: strain differences and alterations of concentrations by physiological and pharmacological stimuli. Sinha YN Endocrinology; 1980 Dec; 107(6):1959-69. PubMed ID: 7428700 [TBL] [Abstract][Full Text] [Related]
9. Probucol, a hypocholesterolemic agent, prevents the development of uterine adenomyosis induced by pituitary grafting in mice. Zhou YF; Mori T; Nagasawa H; Nakayama T; Kubota T; Sakamoto S Anticancer Res; 2004; 24(4):2209-12. PubMed ID: 15330162 [TBL] [Abstract][Full Text] [Related]
10. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats. Lafuente A; Alvarez-Demanuel E; Blanco A; GarcĂa-Bonacho M; Esquifino AI Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151 [TBL] [Abstract][Full Text] [Related]
11. Relationship between incidence and onset age of mammary tumours and uterine adenomyosis in four strains of mice: comparison with the findings of 40 generations previously. Nagasawa H; Kusakawa S In Vivo; 2001; 15(4):345-9. PubMed ID: 11695228 [TBL] [Abstract][Full Text] [Related]
12. Porcine growth hormone and prolactin: concentrations in the fetus and secretory patterns in the growing pig. Klindt J; Stone RT Growth; 1984; 48(1):1-15. PubMed ID: 6724328 [TBL] [Abstract][Full Text] [Related]
13. Peripheral T lymphocyte changes in neonatal piglets: Relationship with growth hormone (GH), prolactin (PRL) and cortisol changes. Borghetti P; De Angelis E; Saleri R; Cavalli V; Cacchioli A; Corradi A; Mocchegiani E; Martelli P Vet Immunol Immunopathol; 2006 Mar; 110(1-2):17-25. PubMed ID: 16213031 [TBL] [Abstract][Full Text] [Related]
14. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat. Gruenewald DA; Naai MA; Marck BT; Matsumoto AM J Androl; 2000; 21(1):72-84. PubMed ID: 10670522 [TBL] [Abstract][Full Text] [Related]
15. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Huseby RA; Soares MJ; Talamantes F Endocrinology; 1985 Apr; 116(4):1440-8. PubMed ID: 3971922 [TBL] [Abstract][Full Text] [Related]
16. Suppression of spontaneous development of uterine adenomyosis and mammary hyperplastic alveolar nodules by Chinese herbal medicines in mice. Mori T; Sakamoto S; Matsuda M; Kyokuwa M; Namiki H; Kuwa K; Kawashima S; Nagasawa H Am J Chin Med; 1993; 21(3-4):263-8. PubMed ID: 8135171 [TBL] [Abstract][Full Text] [Related]
17. Induction of uterine adenomyosis by pituitary grafting and retardation of its development by bromocriptine-mesilate (CB-154) in BALB/c mice. Mori T; Kawashima S; Nagasawa H In Vivo; 1991; 5(2):107-9. PubMed ID: 1768777 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of development of prolactin-induced adenomyosis in mice. Mori T; Nagasawa H Acta Anat (Basel); 1983; 116(1):46-54. PubMed ID: 6858602 [TBL] [Abstract][Full Text] [Related]
19. Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats. Awoniji CA; Roberts D; Chandrashekar V; Hurst BS; Tucker KE; Schlaff WD J Androl; 1996; 17(1):35-40. PubMed ID: 8833739 [TBL] [Abstract][Full Text] [Related]
20. Suppression of spontaneous development of uterine adenomyosis by a Chinese herbal medicine, keishi-bukuryo-gan, in mice. Mori T; Sakamoto S; Singtripop T; Park MK; Kato T; Kawashima S; Nagasawa H Planta Med; 1993 Aug; 59(4):308-11. PubMed ID: 8372144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]